Protocol Ledger

NCT05230758 · Phase III · RECRUITING

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

Interventional Phase III clinical trial protocol NCT05230758 sponsored by Donald Mabbott in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-07-01 Enrollment: 140 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05230758
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)140 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05230758
Protocol FieldVerified Registry Value
NCT IdentifierNCT05230758
Consolidated Lead SponsorDonald Mabbott
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment140 participants (ESTIMATED)
Registered Start Date2022-07-01
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI